# Proposed Committee Members

## Confirmed Discussants

The following individuals were discussed as proposed members at the 13 February 2026 meeting:

| Name | Known Role / Affiliation | Notes |
|------|--------------------------|-------|
| **Dr James Laporta** | Founder & Medical Director, Sanctura | CEO and initiator of the committee |
| **Professor Justin Stebbing** | Strategic partner, UK oncology | Existing relationship with Sanctura UK; provides regulatory guidance and patient referrals |
| **Aida Yousefi** | TBC | Attended the initial planning meeting with Dr Laporta |
| **Mohammed Desai** | TBC | Proposed member |
| **Dr Wendy Denning** | Strategic partner, UK clinic | Existing relationship with Sanctura UK; provides regulatory guidance and patient referrals |

## Additional Names Referenced in Meeting Notes

These names appeared in the meeting notes under the "RWE – strat." section and may be relevant to committee work or specific workstreams:

- **Carrie** — context TBC
- **Ismael** — context TBC

## Items to Clarify

- Formal roles and titles for each member within the committee (e.g., Chair, Secretary)
- Terms of reference for membership (duration, responsibilities, voting rights)
- Whether any members are external advisors vs. internal Sanctura staff
- Professional backgrounds for Aida Yousefi and Mohammed Desai
